574 Results (Page 22 of 23)
Brazil Markets Research Reports
Brazil Vaccines Market Analysis
This report presents a strategic analysis of the Brazil Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Vaccines Market, offering unmatched value, accuracy and expert insights.
Brazil Lipid Disorder Therapeutics Market Analysis
The Brazil Lipid Disorder Therapeutics Market was valued at $627.8 Mn in 2023 and is predicted to grow at a CAGR of 13.13% from 2023 to 2030, to $1,488.9 Mn by 2030. Brazil Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Diseases, the ageing population, and Advancements in Therapeutics and Technologies. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd. Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Brazil Chronic Pain Therapeutics Market Analysis
The Brazil Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.858 Bn in 2022 to $3.168 Bn by 2030, with a CAGR of 6.9% during the forecast period of 2022-2030. The drivers of the Brazil Chronic Pain Therapeutics Market include the increasing incidence among the population owing to changing urban lifestyles, continuous advancements in pain management treatments, and crucial regulatory support and healthcare policies implemented by the Brazilian government. The Brazil Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Novartis, Merck, GSK, Sanofi, Roche, Hypera Pharma, EMS, Biolab Pharma, etc., among various others.
Brazil Dental Fluoride Treatment Market Analysis
The Brazil Dental Fluoride Treatment Market was valued at $379.2 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $530 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Fresh Up Italia, Procter & Gamble Company, Fresh, Colgate-Palmolive and Johnson & Johnson among others.
Brazil Financial Assistance Programs Market Analysis
The Brazil Financial Assistance Programs Market was valued at $708.5 Mn in 2023 and is projected to grow at a CAGR of 15.6% from 2023 to 2023, to $1,954.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, AbbVie, Merck, Sanofi, Johnson & Johnson, Novartis among others.
Brazil Cold Pain Therapy Market Analysis
The Brazil Cold Pain Therapy Market was valued at $55 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $89 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, demand for non-pharmaceutical alternatives in the industry, and focus on sports medicine and rehabilitation. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Sanofi, Ossur, Rohto, Pfizer, and Cardinal Health among others.
Brazil Periodontal Therapeutics Market Analysis
The Brazil Periodontal Therapeutics Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $37.9 Mn by 2030. Brazil Periodontal Therapeutics Market is growing due to Rising Prevalence of periodontitis, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Tokyo Chemical Industry Co. Ltd., Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, and Bausch Health Companies Inc.
Brazil Radiology Service Market Analysis
The Brazil Radiology Service Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Brazil Radiology Service Market are Samaritano, Sirio Libanes, Hospital Mae de Deus, Hospital Saude da Mulher, Hospital Naval Marcilio Dias, Hospital das Clínicas da Unicamp de Campinas, among others.
Brazil Chronic Cough Therapeutics Market Analysis
Brazil Chronic Cough Therapeutics Market was valued at $158 Mn in 2022 and is estimated to reach $316 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The main driver behind the growth of the chronic cough therapeutics market is the extensive prevalence of chronic respiratory infections, often signaled by the occurrence of chronic cough. Presently, key participants in this market consist of GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.
Brazil MRI Market Analysis
The Brazil MRI Market was valued at $166 Mn in 2023 and is predicted to grow at a CAGR of 7.5% from 2023 to 2030, to $275.40 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, rising healthcare investment, and growing demand for accurate diagnosis. The key players in the industry are Koninklijke Philips NV, Neusoft, Esaote, and GE Healthcare among others.
Brazil Hypersomnia Therapeutics Market Analysis
The Brazil Hypersomnia Therapeutics Market was valued at $142.96 Mn in 2023 and is predicted to grow at a CAGR of 5.0% from 2023 to 2030, to $201.17 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Teva, Takeda, and Merck, Jazz Pharmaceuticals among others.
Brazil Dental Implant Market Analysis
Brazil Dental Implant Market was valued at $124.80 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $255.80 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, a growing aging population, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Brazil Conjunctivitis Therapeutics Market Analysis
The Brazil Conjunctivitis Therapeutics Market was valued at $103 Mn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $168 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare accessibility, and expanding pharmaceutical landscape in the industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Sanofi, Santen, and Allergan among others.
Brazil PET Scan Market Analysis
The Brazil PET Scan Market was valued at $48.5 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $74.9 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Brazil PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Brazil Genomic Diagnostics Market Analysis
Brazil Genomic Diagnostics Market was valued at $816.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $2,523.99 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, technological advancements, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Brazil Ear Infection Therapeutics Market Analysis
Brazil Ear Infection Therapeutics Market valued at $295 Mn in 2022, is projected to reach $477 Mn by 2030 with a 6.2% CAGR. The increasing prevalence of ear infections, especially in children, is a major factor contributing to the expansion of the market for therapeutics aimed at treating ear infections. This surge serves as a driving force for substantial research, development efforts, and the introduction of various treatments to tackle this prevalent medical issue. Prominent players in this industry include Pfizer, Novartis, Roche, Johnson & Johnson, Bayer, Merck & Co., AstraZeneca, Sanofi, GlaxoSmithKline, and Takeda Pharmaceutical Company.
Brazil Compression Therapy Market Analysis
Brazil Compression Therapy Market was valued at $95 Mn in 2022 and is estimated to reach $158 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Sigvaris, Medi, Juzo, Jobst, Bauerfeind, Lympha Press, DJO Global, FLA Orthopedics, Al-Medical, and Eurofarma.
Brazil Bio-implant Market Analysis
The Brazil Bio-implant Market was valued at $1625 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $2592.4 Mn by 2030. The Brazil Bio-implant Market is growing due to Increasing Aging population, Technological Advancements, Rising Chronic Disease Prevalence. The market is primarily dominated by players such as Ossur, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Stryker Corporation, Zimmer Biomet, Medtronic, Boston Scientific Corporation, and Johnson & Johnson Services.
Brazil Mouth Ulcer Therapeutics Market Analysis
The Brazil Mouth Ulcer Therapeutics Market was valued at $38 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $53.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Eurofarma, EMS Pharma, ACHE and Sanofi among others.
Brazil Exosome Research Market Analysis
The Brazil Exosome Research Market was valued at $4.2 Mn in 2023 and is projected to grow at a CAGR of 17% from 2023 to 2023, to $12.7 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, Bio-Techne Crop, QIAGEN, Beckam Coulter, Lonza among others.
Brazil Bariatric Surgery Devices Market Analysis
The Brazil Bariatric Surgery Devices Market was valued at $66.5 Mn in 2023 and is projected to grow at a CAGR of 6.2% from 2023 to 2023, to $101.3 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Bhio Supply, Medicone, Scitech Medical, Medtronic, B. Braun, Johnson & Johnson, Cousin Surgery among others.
Brazil CT Scan Market Analysis
Brazil CT Scan Market was valued at $115.25 Mn in 2023 and is predicted to grow at a CAGR of 8.87% from 2023 to 2030, to $208.93 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing population and aging, and government initiatives. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Brazil Mental Health Apps Market Analysis
The Brazil Mental Health Apps Market was valued at $155 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $443.38 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and rising interest in preventive care. The industry is primarily dominated by players such as Headspace, Calm, Meditopia, and Meditation: Lojong among others.
Brazil Constipation Therapeutics Market Analysis
Brazil Constipation Therapeutics Market was valued at $455 Mn in 2022 and is estimated to reach $811 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The constipation therapeutics market is growing driven by the global rise in constipation prevalence associated with aging, sedentary lifestyles, and poor dietary habits, and further fuelled by an expanding elderly population more prone to chronic conditions. Key players in this industry include AbbVie, Allergan, Boehringer Ingelheim, EMS, Farmoquímica, Grünenthal, Johnson & Johnson, Norgine, Pfizer, and Sanofi.
Brazil Herbal Supplements Market Report
The Brazil Herbal Supplements Market was valued at $131.50 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $213.94 Mn by 2030. The key drivers of this industry include health awareness, government support, and growth in the wellness industry. The industry is primarily dominated by players such as Herbalife, Himalaya, NOW Foods, and Botanic Supplements among others.
